Atherosclerotic Plaque Imaging: Coronaries

Imran Rashid; W. Yong Kim; Claudia Prieto; Marcus R. Makowski; Warren J. Manning; René M. Botnar

doi:10.1016/B978-0-323-41561-3.00029-X

Atherosclerotic Plaque Imaging: Coronaries

Imran Rashid, W. Yong Kim, Claudia Prieto, Marcus R. Makowski, Warren J. Manning, René M. Botnar

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Advances in coronary magnetic resonance angiography (CMRA) have yielded improvements in spatial resolution and image acquisition times, highlighting the potential of CMR for comprehensive coronary assessment without the need for ionizing radiation. In addition to plaque burden, noncontrast CMR can provide important information regarding plaque characteristics, such as the presence of thrombus or intraplaque hemorrhage, through the T1-shortening effect of methemoglobin that has proven prognostic utility. Furthermore, contrast-enhanced CMR and molecular imaging using hybrid positron emission tomography and MRI (PET-MR) systems have the potential to identify active cellular and molecular processes that drive atherosclerotic disease progression. These may allow for the precise risk stratification of individuals with subclinical disease in addition to the identification of novel therapeutic targets. Despite challenges, the quality and feasibility of coronary magnetic resonance imaging continues to improve, and its eventual use in combination with MR perfusion, viability, and functional imaging raises the enticing prospect of comprehensive, single modality assessment of patients with ischemic heart disease.

Original language	English
Title of host publication	Cardiovascular Magnetic Resonance: A Companion to Braunwald’s Heart Disease
Pages	343.e3-351.e3
DOIs	https://doi.org/10.1016/B978-0-323-41561-3.00029-X
Publication status	Published - 1 Jan 2018

Keywords

Atherosclerosis
Coronary artery disease
Coronary artery imaging
Magnetic resonance imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-323-41561-3.00029-X

Cite this

@inbook{99c08bb28bd04bf48bc3fa595888abea,

title = "Atherosclerotic Plaque Imaging: Coronaries",

abstract = "Advances in coronary magnetic resonance angiography (CMRA) have yielded improvements in spatial resolution and image acquisition times, highlighting the potential of CMR for comprehensive coronary assessment without the need for ionizing radiation. In addition to plaque burden, noncontrast CMR can provide important information regarding plaque characteristics, such as the presence of thrombus or intraplaque hemorrhage, through the T1-shortening effect of methemoglobin that has proven prognostic utility. Furthermore, contrast-enhanced CMR and molecular imaging using hybrid positron emission tomography and MRI (PET-MR) systems have the potential to identify active cellular and molecular processes that drive atherosclerotic disease progression. These may allow for the precise risk stratification of individuals with subclinical disease in addition to the identification of novel therapeutic targets. Despite challenges, the quality and feasibility of coronary magnetic resonance imaging continues to improve, and its eventual use in combination with MR perfusion, viability, and functional imaging raises the enticing prospect of comprehensive, single modality assessment of patients with ischemic heart disease.",

keywords = "Atherosclerosis, Coronary artery disease, Coronary artery imaging, Magnetic resonance imaging",

author = "Imran Rashid and Kim, {W. Yong} and Claudia Prieto and Makowski, {Marcus R.} and Manning, {Warren J.} and Botnar, {Ren{\'e} M.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-41561-3.00029-X",

language = "English",

pages = "343.e3--351.e3",

booktitle = "Cardiovascular Magnetic Resonance: A Companion to Braunwald{\textquoteright}s Heart Disease",

}

TY - CHAP

T1 - Atherosclerotic Plaque Imaging: Coronaries

AU - Rashid, Imran

AU - Kim, W. Yong

AU - Prieto, Claudia

AU - Makowski, Marcus R.

AU - Manning, Warren J.

AU - Botnar, René M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Advances in coronary magnetic resonance angiography (CMRA) have yielded improvements in spatial resolution and image acquisition times, highlighting the potential of CMR for comprehensive coronary assessment without the need for ionizing radiation. In addition to plaque burden, noncontrast CMR can provide important information regarding plaque characteristics, such as the presence of thrombus or intraplaque hemorrhage, through the T1-shortening effect of methemoglobin that has proven prognostic utility. Furthermore, contrast-enhanced CMR and molecular imaging using hybrid positron emission tomography and MRI (PET-MR) systems have the potential to identify active cellular and molecular processes that drive atherosclerotic disease progression. These may allow for the precise risk stratification of individuals with subclinical disease in addition to the identification of novel therapeutic targets. Despite challenges, the quality and feasibility of coronary magnetic resonance imaging continues to improve, and its eventual use in combination with MR perfusion, viability, and functional imaging raises the enticing prospect of comprehensive, single modality assessment of patients with ischemic heart disease.

AB - Advances in coronary magnetic resonance angiography (CMRA) have yielded improvements in spatial resolution and image acquisition times, highlighting the potential of CMR for comprehensive coronary assessment without the need for ionizing radiation. In addition to plaque burden, noncontrast CMR can provide important information regarding plaque characteristics, such as the presence of thrombus or intraplaque hemorrhage, through the T1-shortening effect of methemoglobin that has proven prognostic utility. Furthermore, contrast-enhanced CMR and molecular imaging using hybrid positron emission tomography and MRI (PET-MR) systems have the potential to identify active cellular and molecular processes that drive atherosclerotic disease progression. These may allow for the precise risk stratification of individuals with subclinical disease in addition to the identification of novel therapeutic targets. Despite challenges, the quality and feasibility of coronary magnetic resonance imaging continues to improve, and its eventual use in combination with MR perfusion, viability, and functional imaging raises the enticing prospect of comprehensive, single modality assessment of patients with ischemic heart disease.

KW - Atherosclerosis

KW - Coronary artery disease

KW - Coronary artery imaging

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=85123657932&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-41561-3.00029-X

DO - 10.1016/B978-0-323-41561-3.00029-X

M3 - Chapter

AN - SCOPUS:85123657932

SP - 343.e3-351.e3

BT - Cardiovascular Magnetic Resonance: A Companion to Braunwald’s Heart Disease

ER -

Atherosclerotic Plaque Imaging: Coronaries

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this